| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 11, 2017Technology VPO Tradeshow News
OnTime Networks, a leading supplier of fully rugged and embedded network connectivity products and systems, announced today that they have entered a Solution Technology Integrator (STI) agreement...
-
Dec 10, 2017Virtual Press Office and PR Newswire: General Trade show news
For people with certain types of aggressive, refractory blood cancers, treatment options are woefully limited. But three studies being presented today at the 59th American Society of Hematology...
-
Dec 10, 2017Virtual Press Office and PR Newswire: General Trade show news
PharmaEssentia USA, a subsidiary of PharmaEssentia Corporation (Taipei Exchange: 6446), today announced the latest follow-up results of Ropeginterferon alfa-2b from the ongoing, long-term,...
-
Dec 9, 2017Virtual Press Office and PR Newswire: General Trade show news
The three-day 2017 Fortune Global Forum opened in Guangzhou on December 6. Chinese property developer Country Garden, a Fortune Global 500 company, became a partner of the forum, where the...
-
Dec 9, 2017Virtual Press Office and PR Newswire: General Trade show news
In four studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers announce promising findings on innovative tools and...
-
Dec 9, 2017Virtual Press Office and PR Newswire: General Trade show news
In three studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report remarkable benefits from new, more easily...
-
Dec 9, 2017Virtual Press Office and PR Newswire: General Trade show news
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced new three-year follow-up data from the RESONATE™-2 study (PCYC-1115/1116), which found that previously-untreated chronic...
-
Dec 9, 2017Virtual Press Office and PR Newswire: General Trade show news
ARMO BioSciences, Inc., a late-stage immuno-oncology company, today released additional clinical trial results on its lead investigational immuno-oncology drug AM0010 (pegilodecakin) in non-small...
-
Dec 8, 2017Virtual Press Office and PR Newswire: General Trade show news
Summit Phoenix, hosted by Dynamic Communities Inc., a business management organization that develops and supports technology-centric user groups, announces registration is now open for Microsoft...
-
Dec 8, 2017Virtual Press Office and PR Newswire: General Trade show news
Summit Phoenix, hosted by Dynamic Communities Inc., a business management organization that develops and supports technology-centric user groups, announces registration is now open for Microsoft...
